Treatment for reactive arthritis or bursitis
US6765000B2 · kind B2 · utility
4Cited by
4References
7Claims
0Family size
Inventors
Key dates
| Filing date | Oct 15, 2002 |
| Grant date | Jul 20, 2004 |
| Priority date | — |
| Expiry date | Oct 15, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of acyclovir, minocycline hydrochloride, and metronidazole. An alternate treatment comprises the combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.